Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idarubicin-based Induction for Ph- High-risk Childhood ALL
NCT01990807Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of idarubicin in acute lymphoblastic leukemia (ALL), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
idarubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01990807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990807.